IQVIA - Global Use of Medicines 2023

IQVIA's Global Use of Medicines report for 2023 provides an overview of the global spending on medicines in 2022 and the outlook for 2027. The report takes into account the impact of the COVID-19 pandemic on global medicine spending and the effect of innovation, loss of exclusivity, and the increased use of generics and biosimilars on the market. The report also includes a detailed analysis of specific therapy areas and countries and aims to provide a foundation for discussion about the value, cost, and role of medicines in the context of overall healthcare spending in the next five years. As the world moves towards a post-pandemic era, policymakers are shifting their focus from crisis management to rebuilding and addressing long-term issues of sustainability in healthcare. The report seeks to inform these discussions by providing evidence-based insights on the global use of medicines.